- Home
- YALA vs DNA Comparison
YALA vs DNA Comparison
Compare YALA & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- DNA
- Stock Information
- Founded
- YALA 2016
- DNA 2008
- Country
- YALA United Arab Emirates
- DNA United States
- Employees
- YALA N/A
- DNA N/A
- Industry
- YALA Computer Software: Programming Data Processing
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YALA Technology
- DNA Health Care
- Exchange
- YALA Nasdaq
- DNA Nasdaq
- Market Cap
- YALA 689.5M
- DNA 562.1M
- IPO Year
- YALA 2020
- DNA N/A
- Fundamental
- Price
- YALA $4.24
- DNA $10.82
- Analyst Decision
- YALA
- DNA Hold
- Analyst Count
- YALA 0
- DNA 6
- Target Price
- YALA N/A
- DNA $37.80
- AVG Volume (30 Days)
- YALA 189.3K
- DNA 1.9M
- Earning Date
- YALA 03-10-2025
- DNA 02-25-2025
- Dividend Yield
- YALA N/A
- DNA N/A
- EPS Growth
- YALA 31.83
- DNA N/A
- EPS
- YALA 0.74
- DNA N/A
- Revenue
- YALA $329,773,319.00
- DNA $217,951,000.00
- Revenue This Year
- YALA $6.23
- DNA N/A
- Revenue Next Year
- YALA $11.04
- DNA N/A
- P/E Ratio
- YALA $5.73
- DNA N/A
- Revenue Growth
- YALA 5.34
- DNA N/A
- 52 Week Low
- YALA $3.71
- DNA $5.26
- 52 Week High
- YALA $5.54
- DNA $64.40
- Technical
- Relative Strength Index (RSI)
- YALA 70.20
- DNA 43.22
- Support Level
- YALA $4.12
- DNA $11.21
- Resistance Level
- YALA $4.25
- DNA $15.96
- Average True Range (ATR)
- YALA 0.10
- DNA 1.85
- MACD
- YALA 0.03
- DNA -0.40
- Stochastic Oscillator
- YALA 90.42
- DNA 0.08
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.